A detailed history of Standard Family Office LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Standard Family Office LLC holds 567 shares of ABBV stock, worth $110,445. This represents 0.12% of its overall portfolio holdings.

Number of Shares
567
Previous 567 -0.0%
Holding current value
$110,445
Previous $103,000 5.83%
% of portfolio
0.12%
Previous 0.14%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $90,617 - $103,250
567 New
567 $103,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $134,867 - $171,460
980 New
980 $150,000
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $109,411 - $135,748
-829 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $89,059 - $112,685
829 New
829 $112,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $59,477 - $67,516
-559 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $44,993 - $60,746
559 New
559 $60,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Standard Family Office LLC Portfolio

Follow Standard Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Standard Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Standard Family Office LLC with notifications on news.